Претраживање
Приказ резултата 41-50 од 106
An investigation into the effect of polymer concentration and tablet size on paracetamol release kinetics from Carbopol 971P matrix tablets / Uticaj koncentracije polimera i veličine tableta na kinetiku oslobađanja paracetamola iz matriks tableta izrađenih sa Carbopolom 971P
(Savez farmaceutskih udruženja Srbije, Beograd, 2002)
Disposition of Lamotrigine in children with epilepsy receiving politherapy / Dispozicija Lamotrigina u kombinovano terapiji dece sa epilepsijom
(Savez farmaceutskih udruženja Srbije, Beograd, 2002)
Biopharmaceutical characterization of drug dosage forms: Basic considerations and importance / Biofarmaceutska karakterizacija lekovitih preparata: osnovni pojmovi i značaj
(Savez farmaceutskih udruženja Srbije, Beograd, 2002)
Investigated of anticoagulation effects of Mg salt of phosphotungstic acid / Ispitivanje antikoagulantnog dejstva Mg soli fosforvolframove kiseline
(Savez farmaceutskih udruženja Srbije, Beograd, 2002)
Influence of disulfiram treatment on 5-HIAA excretions in alcoholics / Uticaj terapije disulfiramom na 5-HIAA ekskreciju kod alkoholičara
(Savez farmaceutskih udruženja Srbije, Beograd, 2002)
Lipid profile in hypothyroid children before and during long-term replacement therapy / Lipidni status u dece sa hipotiroidizmom pre i za vreme dugoročne supstitucione terapije
(Savez farmaceutskih udruženja Srbije, Beograd, 2002)
High-performance liquid chromatographic method for the assay of dexamethasone and xylometazoline in nasal drops containing methyl p-hydroxybenzoate
(Elsevier Science BV, Amsterdam, 2002)
A rapid and sensitive high-performance liquid chromatographic method has been developed for the determination of dexamethasone sodium phosphate (DSP), xylometazoline hydrochloride (XMC) and methyl p-hydroxybenzoate (MHB). ...
Specific processes and requirements in the management of medical products storage / Specifični procesi i zahtevi upravljanja skladištem lekova
(Savez mašinskih i elektrotehničkih inženjera i tehničara Srbije (SMEITS), Beograd, 2002)
The knowledge of raw materials, active and final drug forms are included in the requirements for processing and management of medical product storage. In this paper, the basic guidelines for the final draft of FIP-WHO Good ...